Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;26(2):754-757.
doi: 10.1111/dom.15330. Epub 2023 Oct 22.

Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real-world prospective cohort study

Stefano Zucchini  1 , Carlo Ripoli  2 , Valentino Cherubini  3 , Maria Susanna Coccioli  4 , Maurizio Delvecchio  5 , Rosaria De Marco  6 , Roberto Franceschi  7 , Francesco Gallo  8 , Vanna Graziani  9 , Dario Iafusco  10 , Stefania Innaurato  11 , Anna Lasagni  12 , Fortunato Lombardo  13 , Marco Marigliano  14 , Sara Monti  9 , Filomena Pascarella  15 , Giulia Pezzino  16 , Barbara Predieri  17 , Ivana Rabbone  18 , Riccardo Schiaffini  19 , Michela Trada  20 , Stefano Tumini  21 , Andrea Scaramuzza  22 ; Baqsimi Study Group Collaborators
Collaborators, Affiliations

Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real-world prospective cohort study

Stefano Zucchini et al. Diabetes Obes Metab. 2024 Feb.
No abstract available

Keywords: adolescents; children; hypoglycaemia; nasal glucagon; type 1 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. Singh-Franco D, Moreau C, Levin AD, Rosa D, Johnson M. Efficacy and usability of intranasal glucagon for the management of hypoglycemia in patients with diabetes: a systematic review. Clin Ther. 2020;42:e177-e208.
    1. Deeb LC, Dulude H, Guzman CB, et al. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting. Pediatr Diabetes. 2018;19:1007-1013.
    1. Rabbone I, Missineo A, Zanetta S, et al. Parent and patient knowledge of nasal glucagon use and efficacy in a large cohort of Italian children and adolescents with type 1 diabetes. Diabetes Obes Metab. 2021;23:2004-2005.
    1. Giorgetti C, Ferrito L, Zallocco F, Iannilli A, Cherubini V. Study Group for Diabetes of ISPED. Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy. Ital J Pediatr. 2015;41:74.
    1. Abraham MB, Karges B, Dovc K, et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022;23:1322-1340.

LinkOut - more resources